Overview Rating

Speculative

Technicals Analysis

100

0100

Financials Analysis

0100

Neurocrine Biosciences (NASDAQ:NBIX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Neurocrine Biosciences (NBIX) operate in?

Neurocrine Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Neurocrine Biosciences Stock (NASDAQ: NBIX) stock price, news, charts, stock research, profile.

Open	$138.12
Close	$138.23
Volume / Avg.	410.99K / 796.92K
Day Range	137.36 - 139.03
52 Wk Range	93.28 - 148.37
Market Cap	$13.91B
P/E Ratio	37.36
Dividend Yield	-
Exchange	NASDAQ
RSI	54
Short Interest	2.6%
Days to Cover	3.23

Recent News

Neurocrine Biosciences Says Treatment Can Alleviate Several Symptoms Associated With Depressive Disorder

Neurocrine Biosciences reports Phase 2 data for NBI-1065845 in major depressive disorder. Results show significant improvement in MADRS scores. William Blair sees the potential for $1 billion+ in sales.

Vandana Singh

Analyst Bullish On Gene Therapy-Focused Voyager Therapeutics Sees Best In Class Potential For Its Neurogenetic Medicine Platform

Unlock potential with Voyager Therapeutics as HC Wainwright initiates coverage highlights its TRACER capsid platform, promising CNS-targeted gene therapies and strategic partnerships driving long-term value.

Vandana Singh

Why This Teva Pharmaceutical Analyst Is Turning Bullish On The Austedo Franchise

Shares of Teva Pharmaceutical Industries Ltd (NYSE: TEVA) climbed in early trading on Monday, after several analysts raised their forecasts.

Priya Nigam

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

Apr

May

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Neurocrine Biosciences, Inc.

Sector

Health Care

Industry

Biotechnology

Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in t...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Neurocrine Biosciences (NBIX) stock?

You can purchase shares of Neurocrine Biosciences (NASDAQ:NBIX) through any online brokerage.

View our list of the best stock brokerages

Who are Neurocrine Biosciences (NBIX) competitors?

Other companies in Neurocrine Biosciences’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Cerevel Therapeutics Hldg (NASDAQ:CERE) and Roivant Sciences (NASDAQ:ROIV).

What is the target price for Neurocrine Biosciences (NBIX) stock?

There is no analysis for Neurocrine Biosciences.

What is the forecast for Neurocrine Biosciences (NBIX) stock?

Neurocrine Biosciences has a consensus price target of $146.12.

Current stock price for Neurocrine Biosciences (NBIX)?

The stock price for Neurocrine Biosciences (NASDAQ: NBIX) is $138.23 last updated July 3, 2024 at 1:08 PM EDT.

Does Neurocrine Biosciences (NBIX) pay a dividend?

There are no upcoming dividends for Neurocrine Biosciences.

When is Neurocrine Biosciences (NASDAQ:NBIX) reporting earnings?

Neurocrine Biosciences’s Q2 earnings are confirmed for Tuesday, July 30, 2024.

Is Neurocrine Biosciences (NBIX) going to split?

There is no upcoming split for Neurocrine Biosciences.

What sector and industry does Neurocrine Biosciences (NBIX) operate in?

Neurocrine Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Neurocrine Biosciences

Neurocrine Biosciences (NBIX) Forecast